Nathan K. VanLandingham

University of North Carolina at Chapel Hill

Also affiliated with University of North Carolina Health Care, University of California, San Francisco

Biochemistry, Genetics and Molecular BiologyMedicineImmunology and MicrobiologyComputer Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Therapeutic implications of activating noncanonical PIK3CA mutations in head and neck squamous cell carcinoma”.

Therapeutic implications of activating noncanonical PIK3CA mutations in head and neck squamous cell carcinoma

Journal of Clinical Investigation(2021)10.1172/jci150335

N/A

0DataRank · unranked

60 citations

Bhumsuk Keam, Janice Cho, Michelle J. Lee, Hye Ryun Kim, Hayarpi Torosyan +16 more

The mutational profiles and corresponding therapeutic implications of PI3K mutations in cancer

Advances in Biological Regulation(2022)10.1016/j.jbior.2022.100934

N/A

0DataRank · unranked

11 citations

Andrew Nazarenko, Jennifer R. Grandis, Daniel E. Johnson, Nathan K. VanLandingham

Neddylation as a target in PIK3CA-mutated head and neck cancer

Biochemical and Biophysical Research Communications(2025)10.1016/j.bbrc.2025.151703

N/A

0DataRank · unranked

3 citations

Zhibin Cui, Adila Izgutdina, Nathan K. VanLandingham, Andrew Nazarenko, Liam C. Woerner +5 more